Showing results (441-450 of 1,248) with videos related to
Sort By:
Pageof 125
Infection and Immunity|December 22, 2005
Role in virulence of a Brucella abortus protein exhibiting lectin-like activityTracy H Vemulapalli, Ramesh Vemulapalli, Gerhardt G Schurig, et al.Annals of Biomedical Engineering|December 3, 2009
Simulations of reduced conduction reserve in the diabetic rat heart: response to uncoupling and reduced excitabilityHaisam A Ghaly, Patrick M Boyle, Edward J Vigmond, et al.Head & Neck|March 14, 2009
Neural cell adhesion molecule expression: no correlation with perineural invasion in cutaneous squamous cell carcinoma of the head and neckC Arturo Solares, Ian Brown, Glen M Boyle, et al.Molecular Cancer Therapeutics|April 20, 2013
REST negatively and ISGF3 positively regulate the human STAT1 gene in melanomaJames Amalraj, Samuel J Cutler, Ibtisam Ghazawi, et al.The British Journal of Surgery|April 1, 1993
Expression of p53 in colorectal cancer and dysplasia complicating ulcerative colitisH W Taylor, M Boyle, S C Smith, et al.Veterinary Microbiology|September 24, 2008
The putative penicillin-binding proteins 1 and 2 are important for viability, growth and cell morphology of Brucella melitensisAloka B Bandara, Gerhardt G Schurig, Nammalwar Sriranganathan, et al.Transplantation|June 14, 2000
The relationship between acute rejection and chronic rejection is highly dependent on specific MHC matching: a multi-strain rat heterotopic heart transplant studyJ D Hosenpud, T M Boyle, H Hensler, et al.Journal of Dentistry|July 4, 2009
A centralised, automated dental hospital water quality and biofilm management system using neutral Ecasol maintains dental unit waterline output at better than potable quality: a 2-year longitudinal studyM J O'Donnell, M Boyle, J Swan, et al.British Heart Journal|December 1, 1989
Staffing in cardiology in the United Kingdom 1988. Fifth biennial surveyD Chamberlain, L Bailey, E Sowton, et al.Cancer Chemotherapy and Pharmacology|January 22, 2002
The experimental neuroprotectant leukaemia inhibitory factor (LIF) does not compromise antitumour activity of paclitaxel, cisplatin and carboplatinF M Boyle, C Beatson, R Monk, et al.Pageof 125